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INTRODUCTION
Last decades, the research work on new nano-
structured materials and new nanotechnologies 
has been intensively performed. Nanostructures 
have shown remarkable properties such as high 
thermal stability, excellent mechanical and 
electrical characteristics which allowed them to 
have a wide application in many areas. Due to 
their nano-dimensions, nanoparticles are showing 
environmental and health impacts. There are many 
controversial papers that describe interactions of the 
NPs with the biological systems and rice concern 
that intentional or unintentional human exposure to 
certain types of engineered nanoparticles may lead 
to signiﬁ  cant health i.e. toxicological effects (10, 11). 
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Taking in consideration a very wide application of nanoparticules in different industrial sectors due to their remarkable 
properties for implementation in different products, very important part for future development of nanotechology is following 
a histopatologycal changes provoke of this material.
Silicon carbide (SiC) as ceramic material with high thermal conductivity, high stability, good wear resistance and small 
thermal expansion coefﬁ  cient is very applied in ceramic’s industry, power electronics, biomaterials, pharmaceutics etc. 
Histopathological changes of SiC particles were investigate on 4 weeks old female Wistar rats divided into four groups (two 
control and two experimental groups), sacriﬁ  ced 2, 7 and 14 days after treatment. Histopathological diagnosis was performed 
on heart, liver, spleen, kidneys, lung, brain, gastrointestinal tract, using standard Hematoxilin-eosin staining methods. The 
main toxicological inﬂ  uences of SiC were observed on liver, lungs and gastrointestinal tract.
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Development of the industrial sector based on 
application of engineered nanoparticels -ENPs and 
nanotechnologies is a fast-growing activity. Scientiﬁ  c 
achievements in many areas of nanotechnology 
have been successfully transferred into numerous 
practical applications in the electronics, food, (bio)
pharmaceutical, chemical, cosmetic industry, etc.
(1-4). However, due to their unique size and other 
physicochemical characteristics, they have increased 
the solicitude for the inﬂ  uence on the human health 
and ecological systems(2-4).  Researches in this 
ﬁ  eld are with high priority and several reports on 
the toxicological properties of the ENPs already 
exist with many documented deleterious effects, 
particularly in animals(6-9).
The speciﬁ   c physicochemical properties that 
make nanomaterials useful are the same that may 
hazard the human body and the environment. 
Particle size distribution, surface area, porosity, 
shape, charge density, electrophoretic mobility, 
strength,  ﬂ  exibility,  crystallinity/solubility, 26
stability/(bio)degradability, bio(muco)adhesivity, 
bio-compati-bility, etc., they all can affect the 
biodistribution of the NPs and determine their 
health i.e. toxicological effects. Due to the direct 
contact with the environment, the main entries for 
NPs into the human body are skin, intestinal tract 
and lungs (17, 18). 
Human exposure can be direct or indirect 
through contamination of the environment. Even 
very low concentrations of nanosized materials 
in the air represent very high particle number 
concentrations. In addition, the development of the 
nanotechnology has led to development of various 
strategies for controlled and targeted delivery of 
drugs, vaccines and diagnostics, which includes 
administration of nano-sized delivery systems 
into the human body by different routes (5, 12). 
On the other hand, the different physicochemical 
properties of the engineered nano-sized particles 
(compared with larger sized particles of the same 
components) have raised substantial concerns about 
the safety of the nano-sized materials, intentionally 
or unintentionally entered into the body, because 
the nanosized particles have been considered as the 
most dangerous fraction(13-16).
Recently, many classes of manufactured 
nanoparticles are known. Carbon nanotubes: Multi-
walled carbon nanotubes (MWCNTs) and single-
walled carbon nanotubes (SWCNTs), discovered 
in 1991 by Iijima,  are constituted by a unique 
graphitic sheet or two or more sheets nested together 
in a tubular multilayer structure(1).They posses 
extraordinary properties: high electrical and thermal 
conductivity, great strength and rigidity, energy 
storage and ﬁ  eld emission(2). 
Due to the nanoscale size and carbon backbones, 
harmful and pathogenic effects from the nanotubes 
can arise due to their ability to enter the respiratory 
tract, deposit in the lung tissue, redistribute from 
their site of deposition, escape from the normal 
phagocytic defenses and modify the structure of the 
proteins. In this way, CNTs can potentially activate 
inﬂ   ammatory and immunological responses, 
affecting normal organ functions. 
Inorganic nanoparticles of metal and their 
oxides (Au, Ag, Co, Cr, ZnO, TiO2, CeO2, CrO2): 
Insoluble inorganic NPs can be composed of pure 
metals or their oxides, or various inorganic products 
and alloys (Au, Ag, Co, Cr, ZnO, TiO2, CeO2, CrO2,). 
Only their nanometric dimensions distinguish them 
from the same products normally found on a larger 
scale. Because of their unique properties related to 
their nanometric scale, these particles are precisely 
produced. At this scale, they display mechanical, 
electrical and other properties that do not exist when 
in larger dimensions(9).
Other groups are Quantum dots and 
semiconductors (CdSe, CdTe, ZnSe), Zero-
valent metals (Fe(II)salts),  and Insoluble organic 
nanoparticles.
MATERIALS AND METHODS
Nano-sized Silicon Carbide (SiC) particles 
were used in this experiment. A 0,5% 
hydroxypropylmethylcellulose K4M (HPMC, 
K4M) was used as a suspending agent. A 1,5 g of 
the particles powder was dispersed into the surface 
of 0,5%, w/v HPMC solution (10 ml), and then the 
suspending solutions containing SiC particles were 
treated by ultrasonic for 15-20 min and mechanically 
vibrated for 2-3 min. The size of the particles was 
determined using laser diffractometry (Mastersizer 
Hydro-2000S, Malvern Instruments Ltd., UK). The size 
of the nanoparticles was 10-20 nm. 
Animals and treatment
Four weeks old female Wistar rats (average body 
mass 276+28,38 g) were acclimated during the 2 
week period before starting the experiment. The rats 
were fed rodent diet and ﬁ  ltered water ad libitum. 
At 5th week, the rats were divided into four groups: 
2 control groups, one control, not-treated group 
(n=3) and the second one, vehicle-control group 
(n=9), treated with adequate volume of the solution 
of HPMC in water (0,5% m/v), and 2 experimental 
groups treated with different dose of nanoparticles, 
one (n=9) with a dose of 1 g/kg body weight and the 
second one (n=9) treated with a dose of  5 g/kg body 
weight. After vigorous stirring, suspension of SiC 
nanoparticles containg the correspondent dose of 
nanoparticles was given to rats as a single dose via 
intragastric tube in a minute (according to OECD 
procedure). Food and water were provided 2 h later. 
The symptoms and mortality were observed and 
recorded carefully during the whole period of study. 
No rat died during the study, and they all were active 
and non-anorectic. 
2, 7 and 14 days later, animals from the vehicle-
control and 2 experimental groups were sacriﬁ  ced 
(n=3 per group at each study period). The tissues of 
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heart, liver, spleen, kidneys, lung, brain, small and 
lower intestine were taken and immediately ﬁ  xed 
in a 10% formalin solution for histopathological 
diagnosis. 
Histopathological examination
Histopathological examination was performed 
using standard laboratory procedures. The tissued 
were embedded in parafﬁ  n blocks, then sliced into 
5  μm in thickness were cut. Hematoxylin-eosin 
staining was perform and optical microscope Nicon-
Eclipsa 600 was use for microphotography. 
RESULTS
Macroscopicaly no signiﬁ  cant differences were 
recognized between control and treated groups. 
Due to the inﬂ   uence of the nanoparticules, 
microscopical changes on the tissues of the 
treated groups (heart, liver, spleen, kidneys, 
lungs and gastrointestinal tract) are found with 
histopathological examination. 
Characteristic changes registered at the heart of 
treated animals are shown on the Fig. 1. Congestion 
with diffuse haemorrhages are registered as 
consequence of nanoparticles presence.  
In Fig. 2, characteristic microscopic pictures 
of nanoparticles effects towards lungs are shown. 
Widen interstitial pneumonia with inﬁ  ltration 
of inﬂ   ammatory cells, was noted. Inﬁ  ltration 
                        (а)                                                                                                    (b)                 
Figure1. Heard, treated animals, haemorrhages, (H.E. x10)
of lymphocytes, eosinophils, neutrophils and 
macrophages, mainly are located peribonchialy and 
perivasculary.
                                           
                        (а)                                                                                                    (b)                 
Figure 2. Lungs, treated animals, mononuclear inﬂ  ammations (H.E. x10)
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In Fig. 3, characteristic changes are registered 
at the liver of tested animals. In this organ, as 
consequence of the presence of nanoparticles, the 
stasis with microhaemorrhages are registered, then 
parenchimatous degeneration of hepatocites, sinus 
spaces is part narrowed, there is a presence of 
lymphocytes and eosinoﬁ  les in portal spaces, too. 
                        (а)                                                                                                    (b)                 
Histopathological changes are registered at 
the kidneys of treated animals on Fig. 4. At the 
kidneys, because of nanoparticles presence, stasis, 
haemorrhages, vacuolar degeneration of tubular 
Figure 3. Liver, control group (a), treated animals (b), parenchymatous degeneration, (H.E. x10) 
cells with yellow-brown pigment, are noticed. 
At the spleen, due to nanoparticles presence, 
stasis and yellow-brown pigment, is show on Fig. 5. 
                        (а)                                                                                                    (b)                 
Figure 4. Kidney, treated animals, vacuolar degeneration, (H.E. x20)
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In Fig. 6, changes are registered at the gastro-
intestinal tract (GIT) of treated animals. At the 
GIT due to inﬂ  uence of nanoparticles, reaction of 
                        (а)                                                                                                    (b)                 
Figure 5. Spleen, treated animals, yellow-brown pigment (a) (H.E. x10)
intestinal mucosa and submucosa are registered. 
Also, there are present of lymphocytes, eosinophils 
and plasma cells. 
DISCUSION 
Currently, most NP-related cytotoxicity dates are 
generated by individual studies, where a few speciﬁ  c 
parameters have been monitored for a certain type 
of NP together with a certain cell type. The ﬁ  eld 
of nanotoxicology is steadily gaining importance, 
leading to the generation of more and more date. 
Unfortunately, most date is generated from stand-
along studies, in order to enhance understanding 
of NP induced cytotoxicity, there is an urgent need 
for standardization of the protocols used. Recently, 
emphasis has been placed into understanding the 
                (a)                                                        (b)                                                        (c)               
Figure 6.  GIT, treated animals, colon (a), gaster (b,c), mononuclear inﬁ  ltration, (H.E. x20)
role of the route of particle administration as a 
potential source for toxicity and many researches are 
focused on elucidating the mechanistic underlying 
NP toxicity which is postulated to range from 
inﬂ  ammatory cell inﬁ  ltration and cellular necrosis 
to apoptosis. Among nanoparticles, the smallest, 
anatase, and spherical nanoparticles are consider 
that induced the highest cytotoxic effects (19-21). 
In this paper, several tissues we pointed out 
which could help to optimize nanotoxicology 
studies and to improved understanding of the 
risks for toxicity and health effects of the NPs. 
We noted,  due to the presence of nanoparticles, 
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the stasis and haemorrhages were registered on 
almost all investigated organs. Degeneration of 
hepatocytes and tubular cells of kidney, inﬁ  ltration 
of lymphocytes, eosinﬁ  les and other inﬂ  ammatory 
cells, are main histopathologicaly founding.
Taking in considerations, that many authors 
have identiﬁ   ed two main limitations for identify 
NP toxicity. First, is chronicity of NPs exposure 
and secondly, different studies apply different 
particles and formulations leading to conﬂ  icting 
and unreliable results. Consequently, for the future 
investigations more emphasis should be placed on 
deﬁ  ning the dose of NPs in relation to the route 
of administration. Well summarized results in this 
ﬁ  eld is especially important for the industry and 
sectors where NPs are produced or used in terms of 
providing guidance on the assessment of exposure 
on this materials.
REFERENCES
1. Iijima, S, (1991). Helical microtubules of 
graphite carbon. Nature 354: 56-58. 
2.  Sing R., Pantarotto D., Lacerda L., Pastorin G., 
Klumpp C., Prato M., Bianco A., Kostarelos 
K., PNAS, (2006); 103: 9, 3357-3362. 
3.  Dimitrov A. T., (2009) Study of Carbon 
Nanotubes Production by Electrolysis in Molten 
Li2CO3. Macedonian Journal of Chemistry and 
Chemical Engineering,; 28, 1, 111 
4.    Huczko A., Lange H., (2001) Carbon 
nanotubes: experimental evidence for a null 
risk of skin irritation and allergy. Fullerene Sci. 
Technol.,; 9: 247-250.
5. Drobne D., (2007) Nanotoxicology for safe and 
sustainable nanotechnology. Arh. Hig. Rada 
Toksikol.,; 58: 471-478. 
6. Lam CW, James JT, McCluskey R, Hunter 
RL, (2004) Pulmonary toxicity of single-wall 
carbon nanotubes in mice 7 and 90 days after 
intratracheal instillation. Toxicol Sci;, 77:126-
134. 
7. Shvedova A.A., Kisin E.R., Murray A.R., 
Johnson V.J., Potapovich A.I., Tyurina Y.,   
Gorelik O., (2005) Unusual inﬂ  ammatory and 
ﬁ   brogenic pulmonary responses to single-
walled carbon nanotubes in mice. Am. J. Phy-
siol.,; 289: L698-L708. 
8.  Huczko A., Lange H., Bystrzejewski M., Ba-
ranowski P., (2005) Fullrrenes nanotubes. Car-
bon  Nanostruct.,; 13: 141-145. 
9.  Ostiquy C., Lapointe G., Troltier M., Menard 
L., Cloutier Y., Boutin M.,.Antoun M, Normand 
C., (2006) Health effect nanoparticles. Report 
R-451, IRSST, August.
10.   Pekanen J, Kulmala M., (2004) Exposure 
assessment of ultraﬁ   ne particles in 
epidemiologic time-series studies. Scand. J. 
Work Environ. Health.; 30, 2, 9-18. 
11.    Simko M., Mattsson M-O., (2010) Risks 
from accidental exposure to engineered 
nanoparticles and neurological health effects:a 
critical review. Part. Fibre Toxicology; 7, 42-
57.
12.    Gwinn MR, Vallyathan V., (2006)
Nanoparticles: health effects-pros and cons. 
Environ Health Perspect; 114:1818-1826.
13.   Kipen HM, Laskin DL., (2005) Smaller is 
not always better: nanotechnology yields 
nanotoxicology. Am J Physiol Lung Cell Mol 
Physiol; 289:L696-L697.
14.   Maynard AD, Aitken RJ, Butz T, Colvin V, 
Donaldson K, Oberdorster G, Philbert MA, 
Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, 
Walker NJ, Warheit DB. (2006)Safe handling 
of nanotechnology.  Nature; 444:267-269.
15.  Nemmar A, Hoylaerts MF, Nemery B., (2006) 
Effect of particulate air pollution on hemostasis. 
Clin Occup Eviron Med ; 5:865-81.
16. Grozdanov A., (2008)Personal experience 
regarding nanoosis, Polimeri; 3: 161-163
17.   William W. Yu, Emmanuel C., Drezek R, 
Colvin V.L. ; (2006)Water-soluble quantum 
dots for biomedical applications. Biochemical 
and Biophysical Research Communications;   
348, 781–786. 
18.    Hillyer JF., Albrecht RM., (2001)
Gastrointestinal persorption and tissue 
Ristoski T. et al.31
distribution of differently sized colloidal gold 
nanoparticles, J.Pharm.Sci.; 90(12)1927-1936
19.    Stefaan JS., Pilar RV., Jose-Maria M., 
Wolfgang JP., Stefaan CdS., Kevin B., (2011)
Cellular toxicity of  inorganic nanoparticles: 
Common aspect and guidelines for improved 
nanotoxicity evaluation. Nano Today; 6, 446-
465. 
20.  Lara Y., Nguyen TKT., Marilena L., Alexander 
MS., (2011)Toxicological considerations 
of clinically applicable nanoparticles. Nano 
Today; 6, 585-607. 
21. Sabrina B., Angelique SD., Nathalie HB., 
Martine ML., Cecile R., Doris C., Barbara G., 
Marie C., (2010)Toxicological consequences 
of TiO2, SiC nanoparticles and multi-walled 
carbon nanotubes exposure in several 
mammalian cell types: an in vitro study. J 
Nanopart Res; 12:61-73
Toxically inﬂ  uence of silicon carbide nanoparticles-histopatologycal changes 